CAR T-Cell Therapy for Autoimmune Diseases: Free Eligibility Check for Lupus, Rheumatoid Arthritis, and More

CAR T-cell therapy is emerging as a promising approach for treating severe autoimmune diseases by targeting B cells, which play a crucial role in the pathogenesis of these conditions.

As of June 2025, CAR T-cell therapy programs have opened for the following conditions:

• Lupus (SLE)
• Rheumatoid arthritis
• Systemic Sclerosis (SSC), Scleroderma.
• Dermatomyositis
• Vasculitis
• Sjögren’s syndrome

Contact us to check if you are eligible for this treatment—this is a free service.

Please note that an initial condition for eligibility is that the patient has failed at least 2–3 previous lines of treatment.